Invasive aspergillosis in children with hematologic malignancies

Rashed A Hasan1, Walid Abuhammour

  • 1Michigan State University, Hurley Medical Center, Flint, Michigan 48503, USA.

Paediatric Drugs
|February 24, 2006
PubMed

Insights

Pediatric hematologic malignancy patients with neutropenia and fever require prompt diagnosis of invasive aspergillosis. Early antifungal therapy is crucial due to high mortality, with diagnosis confirmed by culture and imaging.

Area of Science:

  • Mycology
  • Pediatric Hematology
  • Infectious Diseases

Background:

  • Invasive aspergillosis is a severe complication in children with hematologic malignancies.
  • The respiratory tract is the primary site, but systemic dissemination is common.
  • Early diagnosis and treatment are critical for patient outcomes.

Purpose of the Study:

  • To outline diagnostic and therapeutic strategies for invasive aspergillosis in pediatric hematologic malignancy patients.
  • To emphasize the importance of a high index of suspicion and prompt intervention.

Main Methods:

  • Simultaneous use of diagnostic modalities including imaging (radiographs, CT scans) and laboratory tests.
  • Detection of circulating fungal antigens (galactomannan, 1,3-beta-glucan) and polymerase chain reaction (PCR).
  • Definitive diagnosis requires positive culture from sterile sites and evidence of tissue damage.

Main Results:

  • Invasive aspergillosis can disseminate to multiple organs beyond the respiratory tract.
  • Prompt initiation of empiric systemic antifungal therapy (e.g., amphotericin B) is recommended.
  • Surgical intervention has a high mortality rate but may benefit localized disease.

Conclusions:

  • A high index of suspicion is essential in neutropenic children with prolonged fever unresponsive to antibacterials.
  • Multimodality diagnostic approaches are necessary for expeditious diagnosis.
  • Early empiric antifungal treatment is critical due to the high mortality associated with invasive aspergillosis.